ERBB2 and breast carcinoma: Overexpression of PDK1 is sufficient to transform mammary epithelial cells [18] as well as potentiate ErbB2-induced transformation and migration [19], while down-regulation of PDK1 levels inhibits cell proliferation, survival, migration and metastasis of human breast cancer cells [20], [21].